A natural variation is observed at position 4 of the 3′-end of influenza A virus genomes, where U (U4) or C (C4) is present. The replicon activity of C4 was 28% of U4. We compared the transcription and replication activity of U4 [v84(U4)], C4 [v84(C4)] and the complimentary RNA (c84) using the purified influenza virus RNA polymerase in vitro. ApG-primed replication activities of v84(C4) and c84 were 23.8% and 7.8% of v84(U4). Globin mRNA-primed transcription activities of v84(C4) and c84 were 36.9% and 6.81% of v84(U4). De novo replication activities of v84(C4) and c84 were 21.3 and 10.2% of v84(U4). This difference came from their polymerase binding activity. When all the eight genome segments of WSN strain were changed to U4, the virus titer was 760 times higher than the wild type. However, its pathogenicity in mice was lower than the wild type.
Introduction
Influenza A virus contains eight single-stranded (ss) RNA segments of negative polarity as its genome and RNA dependent RNA polymerase (RdRp) as a virion component (Palese and Shaw, 2007) . Influenza virus RdRp catalyzes both transcription [synthesis of plus-strand mRNA containing the host cell-derived cap-1 structure at the 5′-terminus and a poly(A) tail at the 3′-terminus] and replication [synthesis of full-length plus-strand complementary RNA (cRNA) and the cRNA-dependent synthesis of minus-strand viral RNA (vRNA)] (Ishihama and Nagata, 1988) . The viral RdRp also adds poly(A) tail at the 3′-termini of mRNA (Pritlove et al., 1998) . Recently, we purified the recombinant influenza virus RdRp from insect cells and demonstrated all of these activities in our RdRp in vitro (Zhang et al., 2010a) .
All influenza A virus RNA genome segments have 13 and 12 conserved nucleotides at their 5′ and 3′-termini, respectively. These conserved sequences are necessary for the transcription promoter and the replication origin (Fodor and Brownlee, 2002; Neumann et al., 2004) . This structure was first characterized as a "pan-handle structure" (Desselberger et al., 1980; Hsu et al., 1987) and later as a "fork model" (Fodor et al., 1995) , and finally the "cork screw model" was proposed (Flick and Hobom, 1999) . A series of mutational analyses of the 5′ and 3′-termini of the genome sequences of influenza A viruses agreed with the "cork screw model" (Brownlee and Sharps, 2002; Crow et al., 2004; Leahy et al., 2001a,b) . However, the RNA duplex of the 5′ and 3′-RNA fragments agreed with the "pan-handle structure" (Lee et al., 2003) , speculating that the "cork screw" is formed by complex formation with PB1. The "cork screw" structure serves both for the transcription promoter (Fodor and Brownlee, 2002) and the replication origin (Crow et al., 2004; Deng et al., 2006) .
In the conserved 3′-terminal sequence, there is single nucleotide variation at the 4th position from the end; i.e., U (U4) or C (C4). Influenza virus A/WSN/33 contains C in PB2, PB1, PA, and NA at this position, while U is present in the other genomes (Desselberger et al., 1980; Robertson, 1979) . When NA genome contained U4 transcription promoter/replication origin (promoter/origin), its transcription was higher than when it contained C4, and the titer of this virus was higher than that containing C4 (Lee and Seong, 1998) , indicating that the U4 promoter/origin has stronger activity in the cells. The mRNA expression of influenza A/Udorn (H3N2) was found to be as follows; M (U4) N NS (U4) N NP (U4) N NA N HA (U4) N polymerase subunits which had C4 (Hatada et al., 1989) . However, the roles and the mechanisms underlying of the two different promoters/origins of the influenza virus genome are not clear.
In this paper, we directly analyzed the promoter/origin activity of U4 and C4 vRNA and cRNA in vitro using the purified influenza virus RdRp (Zhang et al., 2010a ) and compared their activity in vitro, their replicon activity, their effects on virus growth in the cells and their pathogenicity mice.
Results

Comparison of the U4 and C4 promoter activity in vitro
Recently, we purified the influenza virus RdRp from insect cells (Fig. S1A) . Influenza virus transcription is reconstituted in vitro using the purified RdRp and the model vRNA templates which carry both 5′ and 3′ NTR of the influenza vRNA with globin mRNA, and its replication is reconstituted in vitro using model v-and cRNA templates with or without ApG (Honda et al., 2002; Newcomb et al., 2009; Zhang et al., 2010a) .
Influenza viruses A/WSN/33 and A/PR8/34 contain various combinations of U4 and C4 genome templates. The replicon and template (promoter and origin) activities of two different 3′-ends of vRNA and cRNA templates were compared in replicon and in vitro transcription assays. The replicon activities of NS(U4)luc and NS(C4) luc were compared in a PR8 replicon system (Fig. 1) . The replicon activity of NS(C4)luc was 28 ± 6.0% of that of NS(U4)luc. The replicon activity indicates transcription activity. Therefore, in order to analyze the difference in transcription/replication (promoter/origin) activity of v84(U4), v84(C4) and c84 templates precisely, we compared their activity in vitro using the purified influenza virus RdRp (Fig. 2) .
The purified influenza virus RdRp specifically transcribed and replicated v-and c84 RNA (Fig. 2) (Zhang et al., 2010) , but did not utilize homopolymeric RNA templates with dinucleotide primers (Fig.  S1B ). With ApG, 84 nt RNA were produced from v84, and 84 and 81 nt RNA were produced from c84 (Zhang et al., 2010b) . The relative ApGprimed replication activities of v84(C4) and c84 were 23.8 ± 1.6 and 7.81 ± 0.24% of that of v84(U4), respectively.
Because of the cost of globin mRNA, we first titrated the amount of globin mRNA for v84(U4) and used 0.01 mg/ml of globin mRNA for the transcription in vitro (Fig. S3) . With globin mRNA, 98 and 96 nt RNA were produced from v84 and c84, and the relative globin mRNAprimed transcription activities of v84(C4) and c84 were 36.9 ± 2.6 and 6.81 ± 0.57% of that of v84, respectively. Without primers, 83 nt RNA along with some 84 and 82 nt RNA were produced from v84 and 81 nt RNA were produced from c84, and the relative de novo replication activities of v84(C4) and c84 were 21.3 ± 0.65 and 10.2 ± 0.74% of that of v84(U4), respectively.
The influenza RdRp initiated from the C at the 2nd position from the 3′-end of the genome using 10-15 nucleotide cap-1 primers (Plotch et al., 1979) . Globin mRNA used in this experiment were mixture of mRNA extracted from rabbit reticulocytes. When the different lot of globin mRNA from Sigma was used, only 96 nt products were observed (Fig. S3) . According to the proposed influenza virus transcription initiation scheme (Fodor and Brownlee, 2002) , the 13 nt RNA primer of rabbit β globin mRNA (m 7 GmACACUUGCUUUU, GenBank; M10843) produced the 96 nt products and that the 16 nt RNA primer of rabbit α globin mRNA (m 7 GmACACUUCUGGUCCA, GenBank; V00875) produced the 98 nt products, respectively. In order to confirm that the 98 and 96 nt products of globin mRNAprimed transcription of c84 were transcribed from c84 and not from v84 which was the de novo initiation products of c84, the single-round transcription was performed with heparin ( Fig. 3) . The sensitivity to heparin was tested for ApG-primed and de novo replication of v84 (4U) and c84 templates and 50 μg/ml heparin was used for the condition of the single-round transcription of c84 ( Fig. S4) (Zhang et al., 2010a) . Both 96 and 98 nt products were transcribed from c84 with 0.5 μg globin mRNA in the single-round transcription (Fig. 3) , and we concluded that c84 also served as the template for globin mRNA primer.
Polymerase binding affinity of U4 and C4 promoter/origin
In order to find out the mechanism of differences of template activity between v84(U4) and v84(C4), we compared their binding affinity to RdRp by the competitive UV-crosslink assay (Fig. 4, S5) . First, 0.2 pmol [ 32 P]v84(U4) was used as the probe (Fig. 4A) . The 50% (C4) and v84(U4) was 0.51 pmol and 0.2 pmol, respectively. In conclusion, the binding activity of v84(U4) is 2.4 times higher than that of v84(C4).
Effect of the U4 and C4 promoters on viral replication
In order to test the effect of U4 and C4 promoter/origin on viral replication in the cell, the virus with a C at the 4th position from the 3′-end (AllC4) and one with a U at the same position (AllU4), and the wild type (WSNwt) were reconstituted by the 12 plasmid transfection methods (Neumann et al., 1999) . WSN mutants which had U4 in NS genome (NSU4) and U4 in NA (NAU4) genome were also made. At 72 h after transfection, the viruses were harvested, and their titers were measured by a plaque forming assay in MDCK cells. Their plaque sizes were similar (data not shown). The growth kinetics of AllU4, AllC4, NAU4, NSU4 and WSNwt viruses were examined in MDCK cells. The cells were infected with these viruses at an MOI of 0.01, and the supernatants were collected at 0, 8, 16, 24, 36, 48 , and 60 h after infection. The virus titers were analyzed by a plaque forming assay in MDCK cells (Fig. 5) . The growth curves of WSNwt, NSU4 and AllC4 were similar. The titer of AllC4 was slightly less than WSNwt, but it caught up at 60 h after infection. The viruses were not released until 8 h post infection (pi), after which the viruses were released into the media. The growth kinetics of AllU4 and WSNwt showed similar patterns and plateaued at 48 h pi. The titer of AllU4 was higher than that of WSNwt after 24 h pi. The titer of NAU4 at 8 to 24 h was higher than others, but finally converged between AllU4 and WSNwt. The titers at 60 h pi, when the growth curves had plateaued, were 6.58±4.55 × 10 8 PFU/ml for AllU4, 1.30 ± 0.85 × 10 6 PFU/ml for AllC4, 5.56±0.56 × 10 7 PFU/ml for NAU4, 0.94 ± 0.2 × 10 6 PFU/ml for NSU4 and 0.87 ± 0.39 × 10 6 PFU/ml for WSNwt.
After the growth kinetic analysis, genome RNA were extracted and cloned by RACE to determine their sequences at the 3′-end in order to confirm the absence of mutations in the 3′-end of the genomes. During the growth kinetic experiment, all the viruses kept their 3′ sequences as designed (data not shown).
Pathogenicity in mice
The titer of AllU4 was higher than WSNwt and AllC4 in cultured cells. Finally, the pathogenicity of AllU4 and AllC4 was compared with WSNwt in Balb/c mice (Fig. 6 ). 10 5 and 10 4 PFU of AllC4 did not kill mice at all. All the mice were killed when they were infected with 10 5 PFU of WSNwt and with 10 6 PFU of AllU4. 10 5 PFU of AllU4 killed 50% of mice. LD50 of mouse nasal infection was calculated by Reed and Muench's (1938) method. The LD50 of WSNwt and AllU4 are 1 × 10 4 PFU and 1 × 10 5 PFU, respectively. That of AllC4 is not available because the high titer virus was not obtained.
Interferon β promoter activity
In order to understand the discrepancy of the virus growth in cell culture and the pathogenicity in mice, we measured the interferon β promoter activity of AllU4, AllC4 and WSNwt in infected cells (Fig. 7A ) and NS(U4) and NS(C4) replicons (Fig. 7B ). Interferon β promoter activity of AllU4 (0.051 ± 0.0084) was lower than that of WSNwt Expression of NS1 protein NS(U4) replicon was more active than NS(C4) replicon (Fig. 1) . Interferon α/β are induced by virus ssRNA and dsRNA (Yoneyama and Their survival status was monitored every day. Fujita, 2009). NS(U4) replicon did not activate interferon β promoter as high as NS(C4) although NS(U4) replicon produced more RNA (Fig. 7B) . Interferon production and signaling is inhibited by NS1 protein (Hale et al., 2008) . Therefore, we compared the amount of NS1 in AllU4, AllC4 and WSNwt-infected cells by Western blot (Fig. 7C) . The ratio of NS1 to β-actin in the cells at 8 h post infection of AllC4 (1.1 ± 0.18) was lower than that of WSNwt (1.5 ± 0.05, p b 0.05). That of AllU4 (1.5 ± 0.12) was similar to WSNwt.
Discussion
The highly conserved 5′ and 3′ ends of the influenza virus v-and cRNA serve as the transcription promoter and the replication origin (Deng et al., 2006; Fodor and Brownlee, 2002) . The influenza genome contains U or C at the 4th position of the 3′-end (Desselberger et al., 1980; Robertson, 1979) . U4 promoter enhanced transcription activity by 20-fold in infected cells when C4 was changed to U4 in the NA genome of WSN (Lee and Seong, 1998) . In order to study the difference between U4 and C4 with regard to transcriptional promoter and replication origin, we used replicon and in vitro transcription systems. The replicon activity of C4 promoter was 28 ± 6% of U4 (Fig. 1) . Replicon activity represents transcription of the genome.
Therefore, we compared the promoter/origin activity of U4, C4 and cRNA in vitro (Fig. 2) . The biochemical promoter/origin activity determined in this study was different from that by Lee and Seong (1998) because they measured the amount of RNA in cells. Globin mRNA-priming is an in vitro model of influenza virus transcription and initiation de novo and with ApG is a model of replication. C4 showed weak activity in both transcription and replication, and the replication activity of C4 was weaker than its transcription activity. c84 showed less than 10% template activity of v84(U4).
However, large amount of vRNA was found in the infected cells (Hatada et al., 1989; Lee and Seong, 1998) . The mechanism of large amount of vRNA synthesis from cRNA is the strong affinity of vRNA with RdRp. From the heparin inhibition experiment, RdRp bound to vRNA even after transcription and replication finished ( Fig. S4 ; Zhang et al., 2010a) . Surprisingly, the purified RdRp used globin mRNA as a primer for the c84 template (Fig. 2) although Honda et al. (2001) failed to demonstrate the cleavage of cap-1 RNA of the complementary RNA template, c53. Both c53 and c84 share the identical 3′ and 5′-sequences and served as the template for influenza RdRp . The reason of the controversial results is likely due to the difference of the activity and purity of RdRp. Globin mRNA-primed transcription of c84 was confirmed by the single-round transcription assay with heparin (Fig. 3) . The relative activity of globin mRNAprimed transcription of c84 was lowest because it was not a template for viral mRNA transcription. v84(U4), v84(C4), and c84 used the same cleaved mRNA primers because their product size was identical. Cap 1-priming is concluded to be a biochemical characteristic of influenza virus RNA polymerase.
The promoter binding activity of C4 by RdRp was about 42% of U4 (Fig. 4) , which was higher than its transcription/replication activity (Fig. 2) , indicating that C4 promoter/origin has lower initiation activity than U4.
Finally, the role of the U4 and C4 promoter/origin in viral infection was analyzed. The ratio of U4 and C4 promoter/origin in influenza genomes varies in influenza isolates, and WSN has 4 and 5 genomes that contain C4, respectively (Crescenzo-Chaigne et al., 2002) . Then, WSN mutants containing the U4 (AllU4) or C4 (AllC4) promoter/origin in all 8 genome segments were reconstituted (Fig. 5) . AllU4 showed the same growth kinetics as WSNwt, and plateaued at 48 h after infection. However, its titer was 760 times higher than that of wild type. AllC4 showed slightly slower growth than WSNwt and plateaued at 60 h pi, when their titers were similar. The nucleotide sequences of U4 and C4 were stable, at least by the end of the growth kinetic experiments. AllU4 grew more than NAU4 virus, which does not agree with the previous idea of the C4 promoter economizing viral protein expression (Lee and Seong, 1998) . Furthermore, AllC4 did not attenuate. WSNwt contains C4 in PB2, PB1, PA, and NA. The C4 promoter/origin in NA is likely to attenuate virus growth because low expression of RNA polymerase subunits can supply sufficient amounts of RNA polymerase in infected cells (Inglis and Mahy, 1979; Lamb and Choppin, 1976) . Under low expression of NA by C4 promoter/origin, the expression of NA plays a critical role on virion formation because both HA and NA proteins control virion assembly and budding (Chen et al., 2007) . From the in vitro data of promoter/origin function and their effect on virus replication in the cells, it is concluded that the transcription promoter activity of C4 is 37% and its replication origin activity is 21-24% of U4, and that the virus growth in the cells is affected simply by the strength of promoter/origin.
However, their pathogenicity in mice was different from their growth in the cells. The pathogenicity of AllU4 in mice was lower than that of WSNwt (Fig. 6) . When mice were infected with viruses, infection gradually expanded from the trachea to the deeper sections of the lungs (Manicassamy et al., 2010) . This controversial phenomenon can be explained by innate immunity induced by influenza infection. Influenza virus activated toll-like receptor (TLR) signaling pathway (Wong et al., 2009) . AllU4 produces more ss and double stranded (ds) RNA than WSNwt in the infected cells. In the AllU4-infected mice, innate immunity except type I interferon may be activated more than WSNwt-infected ones through TLR3 and 7 by ss and dsRNA (Kawai and Akira, 2010) , and the AllU4 infected mice survived more than WSNwt-infected ones (Fig. 6) . Influenza infection upregulated TLR3 and induced TLR3 mediated host immune responses (Le Goffic et al., 2006; Le Goffic et al., 2007) . However, interferon β induction of AllU4 was lower than WSNwt and that of NS(U4) replicon was also lower than NS (C4) (Fig. 7) . Type I interferon is inducted by the signal transduction pathway through retinoic-acid inducible gene-I (RIG-I) which is triggered by 5′-triphosphate containing influenza RNA (Kato et al., 2006; Loo et al., 2008; Yoneyama and Fujita, 2009 ). However, RIG-I is inhibited by NS1 protein (Opitz et al., 2007) . In AllU4 infected cells more NS1 proteins, which inhibited the RIG-I derived signal transduction pathway including type I interferon induction, were produced than WSNwt although AllU4 produced more vRNA to stimulate RIG-I (Fig. 7) .
U4 promoter/origin is stronger than C4. However, the virus which has the strongest promoter/origin combination does not exist in the nature and WSN contains both U4 and C4 promoter/origin in its genome segments (Desselberger et al., 1980; Robertson, 1979) . The combination of U4 and C4 promoter/origin of influenza viruses has been selected by the host defense and virus interaction.
Materials and methods
Cell culture
293 T and MDCK cells were maintained in Dulbecco's modified Eagle's minimal essential medium (DMEM) containing 10% and 5% fetal bovine serum (FBS, GIBCO), respectively, 50 U of penicillin (Invitrogen), 50 μg of streptomycin (Invitrogen), and 0.1 mg/ml kanamycin (Invitrogen). TN5 cells were maintained in SF900II containing 1% FBS (Invitrogen), 50 U/ml of penicillin (Invitrogen), 50 μg/ml of streptomycin (Invitrogen), 0.1 mg/ml kanamycin (Invitrogen) and 10 U/ml heparin (Shanghai First Biochemical Pharmaceutical Co.), respectively.
Replicon assay
ppolIPR8NSC4luc, which contains C instead of U at the 4th nucleotide position from the 3′ terminus, was constructed from ppolIPR8NSluc (Toyoda et al., 2003) by PCR amplification using the primers PR8NSC4 f and PR8NS r (Supplementary Table 1) . A standard replicon assay was performed by measuring luciferase activity using the Dual-Glo luciferase assay kit (Promega) and a GloMax 96 Microplate Luminometer (Promega) at 24 h after transfection of 0.1 μg of pCPB2, pCPB1, pCPA, pCNP , ppolINSluc, or ppolIPR8NS4Cluc and 0.01 μg of pRL SV40 (Promega) using Lipofectamine2000 (Invitrogen) as previously published (Toyoda et al., 2003) .
Expression and purification of influenza virus RdRp
Influenza virus RdRp was purified as previously published (Zhang et al., 2010a) . Briefly, TN5 cells were infected with Bac18xHis-PR8PB2 (MOI 5), BacPR8PB1 (MOI 4) and BacPR8PA (MOI 2). At four days after infection, the influenza virus RdRp was extracted from the nuclei with the extraction buffer [500 mM NaCl, 20 mM HEPES-NaOH (pH 7.9), 25% glycerol, 1.5 mM MgCl 2 , 0.1% mercaptoethanol, and 1 tablet/25 ml EDTA-free protease inhibitor cocktail tablets (Roche)] by homogenization in a Dounce homogenizer for 15 strokes with a tight pestle. After gentle extraction at 4°C for 30 m by rotation, the cells were centrifuged in a Beckman 45 Ti rotor at 142 k × g for 30 m. The nuclear extract was applied onto ProBond (Invitrogen) and eluted at 250 mM imidazole after the resin was washed with 10 column volumes of 100 mM imidazole, followed by dialysis against BC200 [20 mM Tris-HCl (pH 7.9), 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 10% glycerol].
In vitro transcription
Influenza RdRp (100 nM) were incubated in 50 mM Tris-HCl (pH 8.0), 8 mM MgCl 2 , 150 mM NaCl, 2 mM DTT, 0.5 mM ATP, 0.5 mM CTP, 0. 
Single-round transcription assay
Ten μM of c84 RNA and 0.5 μg globin mRNA were incubated in 50 mM Tris-HCl (pH 8.0), 8 mM MgCl 2 , 150 mM NaCl, 2 mM DTT, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.05 mM [α- 32 P] UTP, 2000 U/ ml RNase inhibitor, and 5 μM of influenza virus RdRp with or without 50 μg/ml heparin.
Model RNA template
Model RNA templates, v84(4U), v84(4C), and c84, were prepared using MegaShortScript (Ambion) using MboII digested pT7/v84, pT7/ v84(4C), and pT7/c84 .
Competitive RNA UV-crosslink assay 0.2 pmol RdRp and 0.2 pmol [ 32 P]v84(4U) with 0.1, 0.2, 0.4, and 0.8 pmol of v84(4U) or v84(4C) were incubated in 10 μl of 50 mM Tris-HCl (pH 8.0); 8 mM MgCl 2 , 150 mM NaCl and 2 mM DTT at 25°C for 30 m. The reaction mixture was irradiated at a distance of 10 cm for 20 m on ice with a UV lamp (Sanyo). After irradiation, the samples were digested for 30 m at 37°C with 0.2 μg of RNase A. The crosslinked products were analyzed by electrophoresis on SDS-7.5% PAGE. After electrophoresis, the gels were dried and analyzed with Typhoon Trio plus image analyzer (GE). In reverse, 0.2 pmol [ 
In vitro mutagenesis
A C→ U mutation was introduced into ppolI-WSN-PB2, PB1, PA, and NA, and a U → C mutation was introduced into ppolI-WSN-HA, ppolI-NP, ppolI-M, ppolI-NS, and ppolINSluc using the oligonucleotides listed in Table S1 with the QuickChange II Site-Directed Mutagenesis kit (Stratagene). Each mutation was confirmed by sequencing.
Reconstitution of the influenza virus and plaque forming assay
Influenza virus WSN strain (WSNwt) and its mutants (AllU4, AllC4, NAU4 and NSU4 viruses) were reconstituted by transfection of the wild type and the mutant genomes of ppolI-WSN-PB2, ppolI-WSN-PB1, ppolI-WSN-PA, ppolI-WSN-HA, ppolI-WSN-NP, ppolI-WSN-NA, ppolI-WSN-M, and ppolI-WSN-NS with pCPB2, pCPB1, pCPA, and pCNP into 293T cells (Neumann et al., 1999; Toyoda et al., 1996) using Lipofectamine2000 (Invitrogen). At 72 h after transfection, the reconstituted viruses were recovered from culture media and titrated using a plaque forming assay in MDCK cells and stored at −80°C.
Virus growth assay
MDCK cells in a 12-well plate were infected with reconstituted influenza viruses at an MOI of 0.01 at 37°C for 1 h. After being washed five times with PBS, the cells were incubated with 2.5 ml of DMEM, and 2% FBS at 37°C. The supernatants were harvested at 0, 8, 16, 24, 36, 48 , and 60 h after infection and stored at − 80°C. The viruses in the supernatants were titrated using a plaque forming assay in MDCK cells.
Sequence determination of the reconstituted viruses
Viral RNA were extracted with Trizol (Invitrogen) and purified by ethanol precipitation. The purified genome RNA were poly A tailed by 5 U of poly(A) polymerase (New England Biolab) in 50 mM Tris-HCl (pH 7.9), 250 mM NaCl, 10 mM MgCl 2 , and 1 mM ATP at 37°C for 10 min. After the poly(A) tailed genome RNA had been purified by phenol/chloroform extraction and ethanol precipitation, the 3′-ends of the genomic cDNA were collected using a 3′-Full RACE Core set (Takara) with oligonucleotides listed in Table S2 . After the cDNA had been cloned in pGEMT-easy vector (Promega), their sequences were confirmed.
Mice infection
Groups of four six-week-old female Balb/C mice (Sino-British Laboratory Animal) were anaesthetized using ether and inoculated with 50 μl of 10 5 , 10 4 , and 10 3 PFU of WSNwt, All4U and All4C by nasal dropping. Their survival rates were monitored every day for 14 days after infection and 50% lethal dose (LD50) was calculated by the method of Reed and Muench (1938) .
Interferon promoter assay p-125Luc (Yoneyama et al., 1996) was a kind gift from Dr. T. Fujita. 293T cells in 24-well plate were transfected with 0.1 μg of p-125Luc and 0.01 μg of pRL SV40 . The cells were infected with an MOI of 1 of WSN, AllU4 and AllC4 at 16 h after transfection. At 8 h after infection, the cells were harvested and the promoter activity of interferon β was measured as the luciferase activity using the Dual-Glo luciferase assay kit. Luciferase activity was measured at 16 h after transfection of 0.1 μg of pCPB2, pCPB1, pCPA, pCNP, p-125Luc, 0.01 μg of pRL SV40 , and ppolI-WSN-NSwt(U4) or ppolI-WSN-NS(C4). The luciferase activity of p-125Luc transfected 293T cells was subtracted from all of the data.
Measurement of NS1 by Western blot
The amount of NS1 in the cells infected by for 8 h was analyzed by Western blot using anti-NS1 antibodies (Antibody Center, Shanghai Institute of Biological Sciences). Proteins were blotted onto nitrocellulose membranes (Millipore) by semidry electroblotting (BioRad) after 12.5% SDS-PAGE. After the blotted membranes were blocked with 10% skim milk in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 0.02% Tween 20 (TBST), Western blot was performed using rabbit anti-NS1 (1:500), and anti-actin antibodies (1:50, Sigma) as primary antibodies. After the membranes were incubated with alkaline phosphatase-bound anti-rabbit IgG or anti-mouse IgG (1:7500, Promega), the position of the bound antibodies was visualized with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP, Promega).
Chemicals and radioisotopes
Globin mRNA, heparin, UpU and Tris (Trizma) were purchased from Sigma; nucleotides were from GE; [α-32 
